Abstract

Purpose: To investigate whether a combination of radiomics and automatic machine learning applied to dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of primary breast cancer can non-invasively predict axillary sentinel lymph node (SLN) metastasis.Methods: 62 patients who received a DCE-MRI breast scan were enrolled. Tumor resection and sentinel lymph node (SLN) biopsy were performed within 1 week after the DCE-MRI examination. According to the time signal intensity curve, the volumes of interest (VOIs) were delineated on the whole tumor in the images with the strongest enhanced phase. Datasets were randomly divided into two sets including a training set (~80%) and a validation set (~20%). A total of 1,409 quantitative imaging features were extracted from each VOI. The select K best and least absolute shrinkage and selection operator (Lasso) were used to obtain the optimal features. Three classification models based on the logistic regression (LR), XGboost, and support vector machine (SVM) classifiers were constructed. Receiver Operating Curve (ROC) analysis was used to analyze the prediction performance of the models. Both feature selection and models construction were firstly performed in the training set, then were further tested in the validation set by the same thresholds.Results: There is no significant difference between all clinical and pathological variables in breast cancer patients with and without SLN metastasis (P > 0.05), except histological grade (P = 0.03). Six features were obtained as optimal features for models construction. In the validation set, with respect to the accuracy and MSE, the SVM demonstrated the highest performance, with an accuracy, AUC, sensitivity (for positive SLN), specificity (for positive SLN) and Mean Squared Error (MSE) of 0.85, 0.83, 0.71, 1, 0.26, respectively.Conclusions: We demonstrated the feasibility of combining artificial intelligence and radiomics from DCE-MRI of primary tumors to predict axillary SLN metastasis in breast cancer. This non-invasive approach could be very promising in application.

Highlights

  • Breast cancer is a major disease that seriously threatens women’s physical health and quality of life

  • The sentinel lymph node (SLN) status is used to predict the involvement of additional Axillary lymph nodes (ALNs) and is an important indicator to guide the clinical need for ALN dissection (ALND) [3]

  • If SLN metastasis can be predicted with a non-invasive method before surgery, the complications caused by SLN biopsy (SLNB) can be avoided, and the quality of the patient’s life can be greatly improved

Read more

Summary

Introduction

Breast cancer is a major disease that seriously threatens women’s physical health and quality of life. With the development of standardization and precise treatment, requirements for the postoperative quality of life of breast cancer patients have increased. Axillary lymph nodes (ALNs) receive approximately 70% of the lymphatic drainage of the breast and are the most important lymphatic metastatic pathways for breast cancer. The status of ALNs is of great significance for judging the clinical stage of breast cancer, selecting a treatment plan, and evaluating the prognosis [2]. The ALN status plays an important role in adjuvant treatment plan selection after surgery. If SLN metastasis can be predicted with a non-invasive method before surgery, the complications caused by SLNB can be avoided, and the quality of the patient’s life can be greatly improved

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call